Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.05
-$0.23(-1.46%)
At close: 4:00 PM EDT
$14.05
-$0.23(-1.46%)
Day’s Range― - ―
52-Week Range$11.41 - $23.44
Previous CloseN/A
Volume650.92K
Average Volume (3M)2.30M
Market Cap
$1.91B
Enterprise Value$7.80K
Total Cash (Recent Filing)$216.70M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Nov 10, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding130,918,260
10 Day Avg. Volume2,900,015
30 Day Avg. Volume2,297,440
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$18.83Price Target Upside34.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.45
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Same-facility Growth And Physician RecruitmentOrganic growth is supported by higher revenue per case, expanding physician participation and increasing surgical acuity. These drivers can strengthen utilization and referral flows across the network beyond individual acquisitions.
Deleveraging Through Idaho Falls DivestitureA substantial divestiture proceeds inflow could reduce debt and interest burden while simplifying the operating portfolio. A more focused short-stay surgical profile may improve capital allocation and financial flexibility over time.
Expansion Pipeline And Reaffirmed GuidanceReaffirmed targets and a visible de novo pipeline indicate continued capacity expansion despite limited M&A. New facilities can broaden market coverage and support multi-year procedure volume growth if execution remains disciplined.
Bears Say
Persistent Net LossesThe company has not yet converted improving operating performance into consistent bottom-line earnings. Ongoing losses reduce retained capital, constrain shareholder returns and leave results vulnerable to interest and other below-the-line costs.
Elevated Leverage And Interest BurdenHigh leverage and substantial interest expense limit financial flexibility and absorb cash that could fund growth. They also increase sensitivity to operating volatility, refinancing conditions and delays in completing the divestiture.
Margin Pressure And Weaker Cash ConversionLower EBITDA margins and declining free cash flow suggest that cost inflation, mix and spending are limiting conversion of revenue into cash. This could slow debt reduction and weaken the funding available for network expansion.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc’s price range in the past 12 months?
Surgery Partners Inc lowest stock price was $11.41 and its highest was $23.44 in the past 12 months.
What is Surgery Partners Inc’s market cap?
Surgery Partners Inc’s market cap is $1.91B.
When is Surgery Partners Inc’s upcoming earnings report date?
Surgery Partners Inc’s upcoming earnings report date is Nov 10, 2026 which is in 68 days.
How were Surgery Partners Inc’s earnings last quarter?
Surgery Partners Inc released its earnings results on Aug 10, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.058 by $0.042.
Is Surgery Partners Inc overvalued?
According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued.
Does Surgery Partners Inc pay dividends?
Surgery Partners Inc does not currently pay dividends.
What is Surgery Partners Inc’s EPS estimate?
Surgery Partners Inc’s EPS estimate is 0.11.
How many shares outstanding does Surgery Partners Inc have?
Surgery Partners Inc has 130,918,260 shares outstanding.
What happened to Surgery Partners Inc’s price movement after its last earnings report?
Surgery Partners Inc reported an EPS of $0.1 in its last earnings report, beating expectations of $0.058. Following the earnings report the stock price went up 2.704%.
Which hedge fund is a major shareholder of Surgery Partners Inc?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.83 (34.05% Upside)
$18.83 (34.05% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 80%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $143.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Surgery Partners Inc
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized healthy organic performance (revenue growth, strong same-facility metrics, physician recruiting, case acuity expansion, sequential expense improvements) and a strategic portfolio optimization (Idaho Falls sale) expected to simplify the business, improve cash conversion and reduce leverage. Headwinds include a modest decline in adjusted EBITDA and margins year-to-date, higher interest expense, a ~350 bps decline in commercial mix, elevated leverage metrics, and muted M&A activity in 2026. On balance, the positives (organic growth, operational improvements, substantial deleveraging transaction and reaffirmed guidance) outweigh the negatives.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$18.83
▲(34.05% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
1.73% Insiders
24.85% Mutual Funds
3.90% Other Institutional Investors
58.43% Public Companies and
Individual Investors